Literature DB >> 2138558

Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.

T Aebischer1, S Oehen, H Hengartner.   

Abstract

Correlations between the T cell receptor (TcR) V gene usage and the specificity of T cells have been primarily described for major histocompatibility complex (MHC) class II-restricted helper T cell responses. In the present study the TcR genes expressed by MHC class I-restricted murine cytotoxic T cells (CTL) specific for a major epitope of the lymphocytic choriomeningitis virus (LCMV), LCMV-GP2(275-289), were investigated. The TcR primary structure of an LCMV-GP2(275-289) specific H-2Db-restricted CTL clone has been determined. It uses a member of the V alpha 4 family joined to J alpha AN14.4 for the alpha chain and V beta 10 rearranged to D beta 2.1 and J beta 2.4 for its beta chain. Four other independent LCMV-GP2(275-289) specific H-2Db-restricted CTL clones also expressed V alpha 4 and V beta 10 gene elements. Furthermore, V alpha 4 and V beta 10 were preferentially expressed by polyclonal CTL of C57BL/6 origin specific for LCMV. These results suggest that both TcR V alpha and V beta regions are important for the recognition of the LCMV-GP2(275-289) epitope on H-2Db molecules.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138558     DOI: 10.1002/eji.1830200310

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.

Authors:  Y Yanagi; A Tishon; H Lewicki; B A Cubitt; M B Oldstone
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Positive selection of Tcrb-V10b+ T cells.

Authors:  K Tomonari; R Hederer; H Hengartner
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta bias.

Authors:  S C Cose; J M Kelly; F R Carbone
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity.

Authors:  M S Horwitz; Y Yanagi; M B Oldstone
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.

Authors:  C Burkhart; G Freer; R Castro; L Adorini; K H Wiesmüller; R M Zinkernagel; H Hengartner
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes.

Authors:  T Aebischer; D Moskophidis; U H Rohrer; R M Zinkernagel; H Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Functional management of an antiviral cytotoxic T-cell response.

Authors:  M F Bachmann; D E Speiser; P S Ohashi
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

8.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors.

Authors:  S Candéias; J Katz; C Benoist; D Mathis; K Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

10.  Engagement of the T-cell receptor during positive selection in the thymus down-regulates RAG-1 expression.

Authors:  D Brändle; C Müller; T Rülicke; H Hengartner; H Pircher
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.